Let's talk medical research

We’re thrilled to share that today, we announced an important collaboration with Beyond Celiac, the leading celiac disease organization working to ...

We often reference our patient database: 400,000+ patients who have raised their hands to take part in medical research and shared health data to ...

Happy Clinical Trials Day! Here at Antidote, today is an opportunity to talk about why medical research matters – and to celebrate the volunteers who ...

For people living with hemophilia, a chronic condition in which blood doesn’t clot normally, treatment options are limited and the threat of internal ...

Diversity, equity, and inclusion (DEI) is a hot topic in clinical research — and for good reason. If medications aren’t tested on populations that ...

Knee osteoarthritis is the most common form of arthritis worldwide, and its prevalence is expected to continue to rise for years to come. For those ...

When the pandemic began, more than 1,000 trials were delayed as the focus shifted to minimizing coronavirus exposure and driving COVID-19 vaccine and ...

As the COVID-19 pandemic surged in late 2020, the urgency of research was felt by all. At Antidote, our mission has always been to enable faster ...

We’re thrilled to share that Antidote’s Executive Vice President of Business Development, Dave Mauro, has been named to this year’s PharmaVOICE 100. ...

Postoperative Corneal Induced Chronic Pain (also known as CICP) is a condition that causes chronic pain and blurred vision after eye surgery. For the ...